These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14525620)

  • 1. Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof.
    Fisman EZ; Motro M; Tenenbaum A
    Cardiovasc Diabetol; 2003 Sep; 2():11. PubMed ID: 14525620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in cardiovascular diabetology: interleukins and matrixins.
    Fisman EZ; Adler Y; Tenenbaum A
    Adv Cardiol; 2008; 45():44-64. PubMed ID: 18230955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin-15 in cardiovascular diseases.
    Guo L; Liu MF; Huang JN; Li JM; Jiang J; Wang JA
    J Cell Mol Med; 2020 Jul; 24(13):7094-7101. PubMed ID: 32406586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 30 to Interleukin 40.
    Catalan-Dibene J; McIntyre LL; Zlotnik A
    J Interferon Cytokine Res; 2018 Oct; 38(10):423-439. PubMed ID: 30328794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proinflammatory interleukins on jejunal nutrient transport.
    Hardin J; Kroeker K; Chung B; Gall DG
    Gut; 2000 Aug; 47(2):184-91. PubMed ID: 10896908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The biological function and significance of IL-35 in the pathogenesis of atherosclerosis].
    Staciwa M; Broncel M
    Pol Merkur Lekarski; 2018 Apr; 44(262):161-164. PubMed ID: 29775441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a role of interleukin-32 in atherosclerosis.
    Heinhuis B; Popa CD; van Tits BL; Kim SH; Zeeuwen PL; van den Berg WB; van der Meer JW; van der Vliet JA; Stalenhoef AF; Dinarello CA; Netea MG; Joosten LA
    Cytokine; 2013 Oct; 64(1):433-40. PubMed ID: 23727326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low testosterone elevates interleukin family cytokines in a rodent model: a possible mechanism for the potentiation of vascular disease in androgen-deficient males.
    Freeman BM; Mountain DJ; Brock TC; Chapman JR; Kirkpatrick SS; Freeman MB; Klein FA; Grandas OH
    J Surg Res; 2014 Jul; 190(1):319-27. PubMed ID: 24703604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases.
    Sabat R; Wallace E; Endesfelder S; Wolk K
    Expert Opin Ther Targets; 2007 May; 11(5):601-12. PubMed ID: 17465720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in normal and abnormal glucose metabolism.
    Esper RJ; Vilariño JO; Machado RA; Paragano A
    Adv Cardiol; 2008; 45():17-43. PubMed ID: 18230954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti-inflammatory interleukin-35 as an emerging target for antiatherosclerotic therapy.
    Bobryshev YV; Sobenin IA; Orekhov AN; Chistiakov DA
    Curr Pharm Des; 2015; 21(9):1147-51. PubMed ID: 25312725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system].
    Czyzewska-Buczyńska A; Zuk N; Romanowska-Micherda K; Witkiewicz W
    Postepy Hig Med Dosw (Online); 2014; 68():834-41. PubMed ID: 24988604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel interleukin-1 cytokine family members in inflammatory diseases.
    Hahn M; Frey S; Hueber AJ
    Curr Opin Rheumatol; 2017 Mar; 29(2):208-213. PubMed ID: 27926540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-20: biological functions and clinical implications.
    Wei CC; Hsu YH; Li HH; Wang YC; Hsieh MY; Chen WY; Hsing CH; Chang MS
    J Biomed Sci; 2006 Sep; 13(5):601-12. PubMed ID: 16703417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate lymphoid cells type 2 - emerging immune regulators of obesity and atherosclerosis.
    Chalubinski M; Luczak E; Wojdan K; Gorzelak-Pabis P; Broncel M
    Immunol Lett; 2016 Nov; 179():43-46. PubMed ID: 27646628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis.
    Fatkhullina AR; Peshkova IO; Dzutsev A; Aghayev T; McCulloch JA; Thovarai V; Badger JH; Vats R; Sundd P; Tang HY; Kossenkov AV; Hazen SL; Trinchieri G; Grivennikov SI; Koltsova EK
    Immunity; 2018 Nov; 49(5):943-957.e9. PubMed ID: 30389414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of interleukins and their inhibitors in the development of autoimmune uveitis.
    Kuryltsiv NB; Halei KM
    Wiad Lek; 2019; 72(4):716-722. PubMed ID: 31055563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study.
    Herder C; Kannenberg JM; Carstensen-Kirberg M; Huth C; Meisinger C; Koenig W; Peters A; Rathmann W; Roden M; Thorand B
    Cardiovasc Diabetol; 2017 Jan; 16(1):17. PubMed ID: 28143481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
    Fain JN
    Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New inflammation modulator interleukins . Therapeutic implications].
    Lupuşoru CE; Tarţău L; Ghiciuc C
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):24-9. PubMed ID: 12635355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.